InvestSMART

Austco Healthcare Limited (ASX:AHC)

ALERT: Price-sensitive ASX Announcement for AHC
Current share price for AHC : $0.225 -0.11 (-32.84%)+
Release
23 Jul 2025 8:53AM
Price at Release
$0.335
Full Release
download
Summary
On 13 February 2024, Austco Healthcare Limited (ASX:AHC) released a trading update and guidance upgrade, reflecting a strong performance in the first half of FY24. The company announced record unaudited revenue of $25.6 million and EBITDA of $4.2 million for H1 FY24, representing a significant increase compared to the previous corresponding period. The performance was driven by continued demand for its nurse call communication and clinical workflow solutions across several regions, especially North America and Australia. Based on the positive momentum and robust order book, the company upgraded its full-year FY24 revenue and EBITDA guidance. Austco Healthcare remains focused on executing its growth strategy, investing in product innovation, expanding its geographic presence, and capitalizing on opportunities in the global healthcare technology sector.
Key Points
  • Austco Healthcare announced a trading update and guidance upgrade on 13 February 2024.
  • Record unaudited revenue of $25.6 million and EBITDA of $4.2 million for H1 FY24.
  • Significant growth compared to the prior corresponding period.
  • Strong demand for nurse call communication and clinical workflow solutions, particularly in North America and Australia.
  • Upgraded FY24 full-year revenue and EBITDA guidance due to strong order book and positive outlook.
  • Strategic focus on product innovation, market expansion, and global healthcare technology opportunities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.